HyBryte™ Expanded Treatment Continues to Demonstrate Positive Outcomes in Early-Stage Cutaneous T-Cell Lymphoma
January 14, 2025
Host Chris Miglino interviews CEO Jason Matuszewski. He talks about their product, the way that it’s produced, recovered, proccessed, and the way that it supports bodies to recover from wounds.